Dentsply Sirona Expands Leadership Team in Americas
/
/
Dentsply Sirona Expands Leadership Team in Americas

Dentsply Sirona Expands Leadership Team in Americas

Dentsply Sirona, the world’s largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28.

Dentsply Sirona
Mark R. Bezjak , Group Vice President, Americas Regional Commercial Organization at Dentsply Sirona

The appointment supports Dentsply Sirona’s continued focus on strengthening commercial execution, deepening customer relationships, and accelerating growth across the Americas.

Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device industry. He joins Dentsply Sirona from Zimmer Biomet, a global medical technology company, where he most recently served as president of the Americas division. Throughout his career, he has led comprehensive commercial transformations, advanced technology-enabled solutions, and delivered consistent revenue and operating income growth.

“Mark’s appointment is a critical step in ensuring we have the right leadership in place to execute our growth strategy,” said Aldo Denti, EVP and chief commercial officer of Dentsply Sirona. “He brings deep commercial expertise, a strong customer-first mindset, and a proven ability to build high-performing teams, modernize go-to-market strategies, and drive disciplined growth. His experience in orthopedics—a highly demanding, customer-first market where success depends on close clinician engagement, rapid problem-solving, and strong field execution—aligns perfectly with our goal of elevating customer focus and strengthening how we serve the dental community.”

Mr. Bezjak said, “I am excited to join Dentsply Sirona at an important moment for the company. I look forward to working closely with Aldo and the broader leadership team to strengthen commercial execution, support our customers, and build a foundation for sustained growth across the Americas.”

About Mark R. Bezjak

Mr. Bezjak held multiple senior leadership roles at Zimmer Biomet, including president of the Americas, president of North America, and vice president and general manager, North America. He has extensive experience in medical devices, commercial transformation, financial management, and technology-driven growth initiatives. At Zimmer Biomet, Mr. Bezjak led the commercial transition from an implant to a technology company, developed commercial go-to-market strategies for new products, drove pricing strategies, and transformed commercial organizations to achieve enhanced sales and profitability goals. Before joining Zimmer Biomet in 2008, he worked for Arrow International and Michelin North America. Mr. Bezjak holds a Bachelor of Science in Marketing from Virginia Polytechnic Institute and State University (Virginia Tech) and an MBA from the University of Richmond.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices, under a strong portfolio of world-class brands.

Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

DISCLAIMER

This information and any attachment thereto contain “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast,” and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, the ability to integrate the businesses of Dentsply Sirona, and acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the company and Dentsply Sirona in their public filings, including their Annual Reports on Form 10-K and their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

Registered brands, trade names, and logos are used. Even in particular cases when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to different approval and registration timelines, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.

WhatsApp